Literature DB >> 2210059

Leucine metabolism in IDDM. Role of insulin and substrate availability.

L Luzi1, P Castellino, D C Simonson, A S Petrides, R A DeFronzo.   

Abstract

The effect of insulin on plasma amino acid concentrations and leucine metabolism was examined in 18 healthy nondiabetic young volunteers and in 7 subjects with insulin-dependent diabetes mellitus (IDDM) with the euglycemic insulin-clamp technique (40 mU.m-2.min-1) in combination with [1-14C]leucine. All diabetic subjects were studied while in poor metabolic control (fasting glucose 13.3 +/- 1.1 mM; HbA1c 10.8 +/- 0.2%) and again after 2 mo of intensified insulin therapy (fasting glucose 7.2 +/- 0.5 mM; HbA1c 8.0 +/- 0.2%). Insulin-mediated total-body glucose uptake in poorly controlled diabetic subjects (3.6 +/- 0.5 mg.kg-1.min-1) was significantly reduced compared with control subjects (7.5 +/- 0.2 mg.kg-1.min-1; P less than .001) and improved slightly after insulin therapy (4.8 +/- 0.3 mg.kg-1.min-1; P less than .05), although it still remained significantly lower than in control subjects (P less than .01). During the insulin-clamp study performed in subjects with poorly controlled IDDM, endogenous leucine flux (ELF), leucine oxidation (LO), and nonoxidative leucine disposal (NOLD) all decreased (50.1 +/- 2.0 to 26.4 +/- 0.4; 9.2 +/- 0.4 to 6.0 +/- 0.3; 40.9 +/- 2.0 to 20.4 +/- 2.0 mumol.m-2.min-1, respectively) to the same extent as in control subjects. After 2 mo of intensified insulin therapy, the effect of acute hyperinsulinemia on ELF, LO, and NOLD was comparable to that of control subjects, whereas insulin-stimulated glucose metabolism was still impaired. To examine the effect of substrate availability on leucine turnover, well-regulated IDDM and control subjects underwent a repeat insulin-clamp study combined with a balanced amino acid infusion designed to increase circulating plasma amino acid levels approximately twofold. Under these conditions, NOLD was equally enhanced above baseline in both control and IDDM subjects (P less than .01), whereas ELF was inhibited to a greater extent (P less than .01) than during the insulin clamp performed without amino acid infusion (control vs. diabetic subjects, NS). In conclusion, insulin-mediated glucose metabolism is severely impaired in subjects with both poorly controlled and well-controlled IDDM, whereas the effect of acute insulin infusion on leucine turnover is normal, and combined hyperaminoacidemia/hyperinsulinemia stimulated NOLD to a similar extent in both IDDM and control subjects.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2210059     DOI: 10.2337/diacare.39.1.38

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  12 in total

1.  Evidence for a catabolic role of glucagon during an amino acid load.

Authors:  M R Charlton; D B Adey; K S Nair
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

Review 2.  Insulin Regulation of Proteostasis and Clinical Implications.

Authors:  Haleigh A James; Brian T O'Neill; K Sreekumaran Nair
Journal:  Cell Metab       Date:  2017-07-14       Impact factor: 27.287

3.  Metabolic effects of liver transplantation in cirrhotic patients.

Authors:  L Luzi; G Perseghin; E Regalia; L P Sereni; A Battezzati; D Baratti; E Bianchi; I Terruzzi; H Hilden; L C Groop; A Pulvirenti; M R Taskinen; L Gennari; V Mazzaferro
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

4.  Mechanisms of postprandial protein accretion in human skeletal muscle. Insight from leucine and phenylalanine forearm kinetics.

Authors:  P Tessari; M Zanetti; R Barazzoni; M Vettore; F Michielan
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

Review 5.  Protein and diabetes: much advice, little research.

Authors:  Marion J Franz
Journal:  Curr Diab Rep       Date:  2002-10       Impact factor: 4.810

6.  Combined pancreas and kidney transplantation normalizes protein metabolism in insulin-dependent diabetic-uremic patients.

Authors:  L Luzi; A Battezzati; G Perseghin; E Bianchi; I Terruzzi; D Spotti; S Vergani; A Secchi; E La Rocca; G Ferrari
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

7.  Relationship between plasma leucine concentration and clearance in normal and type 1 diabetic subjects.

Authors:  P Tessari; G Biolo; S Inchiostro; L Saggin; A Piccoli; A Tiengo
Journal:  Acta Diabetol       Date:  1992       Impact factor: 4.280

8.  Differential effects of insulin deficiency on albumin and fibrinogen synthesis in humans.

Authors:  P De Feo; M G Gaisano; M W Haymond
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

9.  Protein dynamics in whole body and in splanchnic and leg tissues in type I diabetic patients.

Authors:  K S Nair; G C Ford; K Ekberg; E Fernqvist-Forbes; J Wahren
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

10.  Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes.

Authors:  G Perseghin; G Lattuada; F De Cobelli; A Esposito; F Costantino; T Canu; P Scifo; F De Taddeo; P Maffi; A Secchi; A Del Maschio; L Luzi
Journal:  Diabetologia       Date:  2005-11-01       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.